InMode loses market share to less painful alternatives
The bear case argued: InMode is losing market share as its needle-based radiofrequency technology is deemed obsolete, painful, and prone to extensive patient downtime.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.